Clinical Trial Update: Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and therapeutic efficacy of the VRC01 antibody in patients who started antiretroviral therapy during early acute HIV infecti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC01 antibody (VRC01)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2018-10-17